Neuronal and mixed neuronal glial tumors associated to epilepsy. A heterogeneous and related group of tumours.
The group of brain tumors with mature components encompasses several pathological entities including: the ganglioneuroma; the gangliocytoma; the ganglioglioma; the desmoplastic ganglioglioma; the neurocitoma and a group of glioneuronal hamartomatous tumorous lesions, such as meningoangiomatosis. The dysembryoplastic neuroepithelial tumor is characterized by the presence of multiple cortical nodules made up of small, oligo-like cells and a myxoid pattern rich in mucopolysaccharides. Mature neuronal cells are frequently detected throughout the tumor. Most of them are associated with microhamartias in the adjacent brain and pharmacoresistant epilepsy. The excellent prognosis of the majority of these tumors and the potential for malignant transformation of the glial component in the ganglioglioma are the two most remarkable findings. Histological signs of anaplasia and greater mitotic and proliferative activities are associated with local recurrences. Atypical neurocytomas occur only exceptionally. Treatment choices are surgical resectioning and, in those cases presenting greater proliferative activity and cytological atypia, postoperative radiotherapy may be recommended. This paper reviews this heterogeneous group of neoplasms and hamartomatous lesions, pointing out presumable transitions among the different types of mixed neuronal and glial brain tumors. A single term of "mixed neuronal-glial tumors" is defended, distinguishing different subgroups of tumors, depending on the predominant cellular component.
Moreno
A
A
Department of Pathology, Clínica Puerta de Hierro, Madrid, Spain.
de Felipe
J
J
García Sola
R
R
Navarro
A
A
Ramón y Cajal
S
S
D000328:Adult; D001932:Brain Neoplasms / Q000150:complications / Q000473:pathology*; D002648:Child; D004827:Epilepsy / Q000209:etiology* / Q000473:pathology; D018303:Ganglioglioma / Q000150:complications / Q000473:pathology*; D005910:Glioma / Q000150:complications / Q000473:pathology*; D006222:Hamartoma / Q000150:complications / Q000473:pathology*; D006801:Humans; D011379:Prognosis